fleroxacin has been researched along with Cronobacter Infections in 3 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A clinical study was conducted on fleroxacin (FLRX) in 143 patients and carriers with infectious enteritis (shigellosis, Salmonella enteritis, Campylobacter enteritis, pathogenic Escherichia coli enteritis, Vibrio parahaemolyticus enteritis, cholera, multiple bacterial infections, pathogen-negative enteritis)." | 9.07 | [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis]. ( Ajisawa, A; Masuda, G; Murata, M; Negishi, M; Nitta, Y; Sagara, H; Takizawa, Y; Tomizawa, I; Tsunoda, T; Yamaguchi, T, 1994) |
| "The penetration, pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin were investigated in a rat abscess model." | 7.67 | The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model. ( Barzilai, A; Keren, G; Leibovitz, E; Rubinstein, E; Shabtai, M, 1989) |
| "A clinical study was conducted on fleroxacin (FLRX) in 143 patients and carriers with infectious enteritis (shigellosis, Salmonella enteritis, Campylobacter enteritis, pathogenic Escherichia coli enteritis, Vibrio parahaemolyticus enteritis, cholera, multiple bacterial infections, pathogen-negative enteritis)." | 5.07 | [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis]. ( Ajisawa, A; Masuda, G; Murata, M; Negishi, M; Nitta, Y; Sagara, H; Takizawa, Y; Tomizawa, I; Tsunoda, T; Yamaguchi, T, 1994) |
| "The penetration, pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin were investigated in a rat abscess model." | 3.67 | The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model. ( Barzilai, A; Keren, G; Leibovitz, E; Rubinstein, E; Shabtai, M, 1989) |
| "Fleroxacin and cefetamet were evaluated in vitro against 38 infrequently encountered species (250 strains) of the family Enterobacteriaceae and compared with four established compounds." | 1.28 | In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin. ( Altwegg, M; Hohl, P; Lüthy-Hottenstein, J; Zollinger-Iten, J, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagara, H | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Nitta, Y | 1 |
| Tsunoda, T | 1 |
| Yamaguchi, T | 1 |
| Masuda, G | 1 |
| Negishi, M | 1 |
| Ajisawa, A | 1 |
| Murata, M | 1 |
| Hohl, P | 1 |
| Lüthy-Hottenstein, J | 1 |
| Zollinger-Iten, J | 1 |
| Altwegg, M | 1 |
| Leibovitz, E | 1 |
| Keren, G | 1 |
| Shabtai, M | 1 |
| Barzilai, A | 1 |
| Rubinstein, E | 1 |
1 trial available for fleroxacin and Cronobacter Infections
| Article | Year |
|---|---|
[Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis].
Topics: Adolescent; Adult; Aged; Campylobacter Infections; Drug Administration Schedule; Dysentery, Bacillar | 1994 |
2 other studies available for fleroxacin and Cronobacter Infections
| Article | Year |
|---|---|
In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftizoxime; Ceftriaxone; Ciprofloxacin; Clavulanic Acid; Clavul | 1990 |
The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
Topics: Abscess; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Disease Models, Ani | 1989 |